Pharmaceutical industry – Page 50

Opinion
The never-ending story

2013-09-02T00:00:00Z

Keeping up with the literature is impossible, says Derek Lowe.
Business
Endo Health to buy Boca Pharmacal for $225m

2013-09-02T00:00:00Z

Endo agrees to buy generics firm Boca as two major patents expire
Business
Nice rules against Afinitor

2013-08-30T00:00:00Z

Novartis’ drug will not routinely be available on the UK health service
Business
Couple charged in GSK corruption investigation

2013-08-29T00:00:00Z

Two private investigators have been charged with breaching the privacy rights of Chinese citizens
Business
J&J buys Aragon’s prostate cancer arm

2013-08-22T00:00:00Z

Hormone cancer specialist spins out other programmes before sale
Business
Two way traffic for Chinese drug licensing

2013-08-21T00:00:00Z

Western companies are seeing more value in Chinese innovation
Business
Boehringer to close manufacturing plants and cut jobs

2013-08-20T00:00:00Z

Two US plants and a total of 640 jobs to go by the end of next year
News
Chinese drug watchdog set for major reforms

2013-08-19T00:00:00Z

Measures will speed up drug approvals and decentralise controls on generics
News
Indian U-turn on diabetes drug ban

2013-08-16T00:00:00Z

Suspension of cheap and popular medicine reversed but will now come with new safety warnings
Business
Antiviral patents released by Roche

2013-08-06T00:00:00Z

Firm will supply cheap drugs and allow generics in developing countries
News
Execution drug cannot be imported into US

2013-08-05T00:00:00Z

Court rules that the Food and Drug Administration acted unlawfully allowing sodium thiopental into the country
Business
India revokes more pharma patents

2013-08-02T00:00:00Z

Original molecule patent stands, but a new salt form is ‘not innovative’
Business
Pfizer reshuffle hints at future split decision

2013-07-31T00:00:00Z

Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
Business
Perrigo bags Elan and its bargain Irish tax rates

2013-07-31T00:00:00Z

$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
Business
Thousands face job cuts after Valeant's Bausch buyout

2013-07-30T00:00:00Z

Valeant plans to shed 10-15% of its workforce to save $800 million
Business
China corruption investigation broadens

2013-07-29T00:00:00Z

GSK scandal is the trigger to clean up Chinese drug market
Business
Lilly freezes pay as patent cliff looms

2013-07-24T00:00:00Z

Drugmaker targets $400 million savings as two key patents near expiry
Business
GSK under investigation over corruption in China

2013-07-12T00:00:00Z

Police claim executives engaged in bribery and tax-related crimes
Business
Evotec moves business back to UK

2013-07-09T00:00:00Z

Pharma company closes operations in India, citing distance from customers
Business
Biosimilar drugs step up complexity

2013-07-02T00:00:00Z

First generic monoclonal antibodies recommended for approval in Europe